Clinical Trials Directory

Trials / Unknown

UnknownNCT02735395

Dose and Duration of Metronidazole and Amoxicillin for Treatment of Chronic Periodontitis

Impact of Different Dosages and Time of Administration of Metronidazole and Amoxicillin in the Treatment of Generalized Chronic Periodontitis: A Randomized Clinical Trial

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
110 (actual)
Sponsor
University of Guarulhos · Academic / Other
Sex
All
Age
30 Years
Healthy volunteers
Not accepted

Summary

The aim of this study was to compare the clinical and microbiological outcomes of different dosages of metronidazole (MTZ) and of the duration of the systemic administration of MTZ and amoxicillin as adjunct to scaling and root planing (SRP) in the treatment of generalized chronic periodontitis (GChP).

Detailed description

Randomized clinical trials and systematic reviews have shown that the use of the combination of metronidazole (MTZ) and amoxicillin (AMX) significantly improves the benefits of the SRP in the treatment of subjects with periodontitis. However, the optimal dosage and interval of administration of these antibiotics are still unclear. Therefore, the aim of this study was to compare the clinical and microbiological outcomes of different dosages and duration of the systemic administration of the combination of MTZ and AMX as adjunct to scaling and root planing (SRP) in the treatment of generalized chronic periodontitis (GChP). One hundred ten subjects will be randomly assigned to receive SRP plus placebo, or SRP combined with 250 mg or 400 mg of MTZ, plus AMX (500 mg) TID, for either 7 or 14 days. Subjects will be clinically and microbiologically monitored up to 1 year post-therapy.

Conditions

Interventions

TypeNameDescription
PROCEDUREScaling and root planing (SRP)SRP performed in four to six appointments lasting approximately 1 h each, using manual curettes (Hu-Friedy, Chicago, IL, USA) and ultrasonic device (Cavitron Select SPC, Dentsply professional, York, PA, USA) under local anesthesia. The deep sites will be scaled throughout the first week and treatment of the entire oral cavity will be completed in 14 days.
DRUGMetronidazole 250 (7 days)Subjects will intake Metronidazole 250 mg. for 7 days, starting immediately after the first session of Scaling and Root Planing.
DRUGMetronidazole 400 (7 days)Subjects will intake Metronidazole 400 mg. for 7 days, starting immediately after the first session of Scaling and Root Planing.
DRUGMetronidazole 250 (14 days)Subjects will intake Metronidazole 250 mg. for 14 days, starting immediately after the first session of Scaling and Root Planing.
DRUGMetronidazole 400 (14 days)Subjects will intake Metronidazole 400 mg. for 14 days, starting immediately after the first session of Scaling and Root Planing.
DRUGAmoxicillinSubjects will intake Amoxicillin 500 mg. for 14 days, starting immediately after and the first session of Scaling and Root Planing.
OTHERPlacebo 250 (7 days)Subjects will intake placebo of Metronidazole 250 mg. for 7 days, starting immediately after to intake Metronidazole 250 mg.
OTHERPlacebo 400 (7 days)Subjects will intake placebo of Metronidazole 400 mg. for 7 days, starting immediately after to intake Metronidazole 400 mg.
OTHERPlacebo 400 (14 days)Subjects will intake placebo of Metronidazole 400 mg. for 14 days, starting immediately after the first session of Scaling and Root Planing.
OTHERPlacebo 500Subjects will intake placebo of Amoxicillin 500 mg. for 14 days, starting immediately after the first session of Scaling and Root Planing.

Timeline

Start date
2011-07-01
Primary completion
2014-05-01
Completion
2020-12-01
First posted
2016-04-12
Last updated
2020-01-13

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT02735395. Inclusion in this directory is not an endorsement.